Clinical Quiz: An Old Lady with Oedema of All Four Limbs

Kapur N.K. , Musunuru K. Clinical efficacy and safety of statins in managing cardiovascular risk. Vasc Health Risk Manag 2008; 4(2): 341–53.

AstraZenaca. Drug Substance rosuvastatin calcium. Periodic Safety Update Report, 19th Dec 2006. [cited 2009 May 14]. Available from: http://www.trouw.nl/redactie/psur/Crestor%20PSUR/Crestor%20PSUR%202006%20p%2022–46.pdf

Kaufmann P. , Török M. , Zahno A. , Waldhauser K.M. , Brecht K. , Krähenbühl S. Toxicity of statins on rat skeletal muscle mitochondria. Cell Mol Life Sci 2006; 63(19-20): 2415–25.

McAfee A.T. , Ming E.E. , Seeger J.D. , Quinn S.G. , Ng E.W. , Danielson J.D. The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy. Pharmacoepidemiol Drug Saf 2006; 15(7): 444–53.

Bays H. Statin safety: an overview and assessment of the data - 2005. Am J Cardiol 2006; 97(8A): 6C–26C.

Radcliffe K.A. , Campbell W.W. Statin myopathy. Curr Neurol Neurosci Rep 2008; 8(1): 66–72.